Show Summary Details
Page of

Pharmacoeconomics 

Pharmacoeconomics
Chapter:
Pharmacoeconomics
Author(s):

Scott K Griggs

and Peter Hurd

DOI:
10.1093/med/9780190238308.003.0011
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 October 2018

Although pharmacoeconomic justifications often examine dollars spent or lives saved, the implications for the health of communities are equally important. Given the significant and growing cost of health care and medications, decision-makers face the difficult dilemma of choosing how best to optimize resources efficiently and effectively (relating to outcomes in the real world). This chapter defines terms and categories commonly used in pharmacoeconomic evaluations and offers a comparative review of four commonly used methodologies. It also examines the steps involved in pharmacoeconomic evaluation, as well as how to critically evaluate published studies. This leads to a discussion on the use of decision analysis in pharmacoeconomic studies. The chapter argues that a background in pharmacoeconomics is essential for pharmacists as drug therapy becomes more complicated and their roles as members of interdisciplinary teams of health care providers expand.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.